Sanket U. Shah

1.4k total citations
32 papers, 982 citations indexed

About

Sanket U. Shah is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Sanket U. Shah has authored 32 papers receiving a total of 982 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Ophthalmology, 16 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Oncology. Recurrent topics in Sanket U. Shah's work include Ocular Oncology and Treatments (15 papers), Retinal Diseases and Treatments (10 papers) and Glaucoma and retinal disorders (8 papers). Sanket U. Shah is often cited by papers focused on Ocular Oncology and Treatments (15 papers), Retinal Diseases and Treatments (10 papers) and Glaucoma and retinal disorders (8 papers). Sanket U. Shah collaborates with scholars based in United States, United Kingdom and Brazil. Sanket U. Shah's co-authors include Carol L. Shields, Jerry A. Shields, Swathi Kaliki, Sara E. Lally, S Ferenczy, Carlos Bianciotto, Arman Mashayekhi, Emil Anthony T. Say, Saad Al-Dahmash and Raj K. Maturi and has published in prestigious journals such as Ophthalmology, Drugs and Investigative Ophthalmology & Visual Science.

In The Last Decade

Sanket U. Shah

32 papers receiving 952 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sanket U. Shah United States 18 911 403 188 152 135 32 982
E. Rand Simpson Canada 18 954 1.0× 334 0.8× 222 1.2× 117 0.8× 164 1.2× 44 1.0k
Yacoub A. Yousef Jordan 17 901 1.0× 323 0.8× 289 1.5× 227 1.5× 104 0.8× 78 1.0k
Hatem Krema Canada 18 571 0.6× 137 0.3× 192 1.0× 158 1.0× 117 0.9× 60 739
María A. Saornil Spain 18 558 0.6× 223 0.6× 152 0.8× 71 0.5× 207 1.5× 55 777
Jorge E. Freire United States 11 615 0.7× 220 0.5× 175 0.9× 91 0.6× 100 0.7× 23 683
Carol L. Shields United States 7 518 0.6× 178 0.4× 165 0.9× 82 0.5× 75 0.6× 10 666
Fairooz P. Manjandavida India 8 482 0.5× 165 0.4× 112 0.6× 80 0.5× 62 0.5× 15 539
Jerry A. Shields United States 15 518 0.6× 95 0.2× 163 0.9× 110 0.7× 117 0.9× 23 636
Carol L. Shields United States 12 548 0.6× 144 0.4× 157 0.8× 106 0.7× 136 1.0× 18 677
Nils Eide Norway 15 451 0.5× 119 0.3× 147 0.8× 48 0.3× 158 1.2× 41 595

Countries citing papers authored by Sanket U. Shah

Since Specialization
Citations

This map shows the geographic impact of Sanket U. Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanket U. Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanket U. Shah more than expected).

Fields of papers citing papers by Sanket U. Shah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanket U. Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanket U. Shah. The network helps show where Sanket U. Shah may publish in the future.

Co-authorship network of co-authors of Sanket U. Shah

This figure shows the co-authorship network connecting the top 25 collaborators of Sanket U. Shah. A scholar is included among the top collaborators of Sanket U. Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanket U. Shah. Sanket U. Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shah, Sanket U., et al.. (2021). Deferiprone (Ferriprox) as newer iron chelator in thalassaemia major patients. Research Journal of Pharmacy and Technology. 14(2). 1041–1044. 4 indexed citations
2.
Shah, Sanket U., et al.. (2020). Primary Pulmonary Synovial Sarcoma in a 49-Year-Old Male. Cureus. 12(12). e11899–e11899. 4 indexed citations
3.
Shah, Sanket U. & Raj K. Maturi. (2017). Therapeutic Options in Refractory Diabetic Macular Oedema. Drugs. 77(5). 481–492. 22 indexed citations
4.
Ambiya, Vikas, Sanket U. Shah, Chintan Sarvaiya, et al.. (2016). Subfoveal choroidal thickness as a predictor of central serous chorioretinopathy. Eye. 30(12). 1623–1629. 17 indexed citations
5.
6.
Shah, Sanket U., et al.. (2013). ASSESSMENT OF THE RISK OF NEEDLESTICK INJURIES ASSOCIATED WITH INTRAVITREAL INJECTIONS. Retina. 34(4). 781–784. 6 indexed citations
7.
Shah, Sanket U., Arman Mashayekhi, Carol L. Shields, et al.. (2013). Uveal Metastasis from Lung Cancer. Ophthalmology. 121(1). 352–357. 106 indexed citations
8.
Shah, Sanket U., Suman Pilli, David G. Telander, Lawrence S. Morse, & Susanna S. Park. (2013). Survey of patients with age-related macular degeneration: knowledge and adherence to recommendations. Canadian Journal of Ophthalmology. 48(3). 204–209. 19 indexed citations
9.
Zutis, Kris, et al.. (2013). Towards automatic detection of abnormal retinal capillaries in ultra-widefield-of-view retinal angiographic exams. PubMed. 45. 7372–7375. 4 indexed citations
10.
Shields, Carol L., Swathi Kaliki, Sanket U. Shah, et al.. (2012). Iris Melanoma Features And Prognosis In Children And Adults In 317 Patients. Investigative Ophthalmology & Visual Science. 53(14). 3385–3385. 5 indexed citations
11.
Shields, Carol L., et al.. (2012). Giant Ocular Surface Squamous Neoplasia Managed with Interferon Alpha-2b as Immunotherapy or Immunoreduction. Ophthalmology. 119(5). 938–944. 62 indexed citations
12.
Ramasubramanian, Aparna, et al.. (2012). Resection of Intraocular Tumors (Partial Lamellar Sclerouvectomy) in the Pediatric Age Group. Ophthalmology. 119(12). 2507–2513. 16 indexed citations
13.
Shields, Carol L., Swathi Kaliki, Saad Al-Dahmash, et al.. (2012). Interferon for Ocular Surface Squamous Neoplasia in 81 Cases. Cornea. 32(3). 248–256. 89 indexed citations
14.
Shah, Sanket U. & David C. Gritz. (2012). Application of the femtosecond laser LASIK microkeratome in eye banking. Current Opinion in Ophthalmology. 23(4). 257–263. 5 indexed citations
15.
Shields, Carol L., et al.. (2012). Iris melanoma: Features and prognosis in 317 children and adults. Journal of American Association for Pediatric Ophthalmology and Strabismus. 16(1). 10–16. 93 indexed citations
16.
Shields, Carol L., Swathi Kaliki, Sanket U. Shah, et al.. (2011). Minimal Exposure (One or Two Cycles) of Intra-arterial Chemotherapy in the Management of Retinoblastoma. Ophthalmology. 119(1). 188–192. 46 indexed citations
17.
Kaliki, Swathi, Sanket U. Shah, Ann Leahey, Carlos Bianciotto, & Carol L. Shields. (2011). Postenucleation Adjuvant Chemotherapy With Vincristine, Etoposide And Carboplatin In Patients With High Risk Retinoblastoma. Investigative Ophthalmology & Visual Science. 52(14). 2109–2109. 1 indexed citations
18.
Say, Emil Anthony T., Sanket U. Shah, S Ferenczy, & Carol L. Shields. (2011). Optical Coherence Tomography of Retinal and Choroidal Tumors. Journal of Ophthalmology. 2011. 1–12. 58 indexed citations
19.
Shah, Sanket U., Carol L. Shields, Carlos Bianciotto, et al.. (2011). Plaque Radiotherapy for Residual or Recurrent Iris Melanoma after Surgical Resection in 32 Cases. Ophthalmology. 119(4). 838–842.e2. 17 indexed citations
20.
Kagemann, Larry, et al.. (2002). The Clinical Importance of Ocular Perfusion Pressure Calculation With Systemic Medication. Investigative Ophthalmology & Visual Science. 43(13). 331–331. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Rand Simpson Breakdown of academic impact, for papers by Yacoub A. Yousef Breakdown of academic impact, for papers by Hatem Krema Breakdown of academic impact, for papers by María A. Saornil Breakdown of academic impact, for papers by Jorge E. Freire Breakdown of academic impact, for papers by Carol L. Shields Breakdown of academic impact, for papers by Fairooz P. Manjandavida Breakdown of academic impact, for papers by Jerry A. Shields Breakdown of academic impact, for papers by Carol L. Shields Breakdown of academic impact, for papers by Nils Eide
Rankless by CCL
2026